Bayer CEO Draws Parallels Between His Skateboarding Accident and Company's Challenges

Bayer CEO Bill Anderson drew parallels between his skateboarding accident and the challenges facing the company. Facing loss of exclusivity of best-selling drugs, heavy debt burden, and costly litigation after the Monsanto takeover, Bayer is struggling. Anderson, tasked with resurrecting the company, faces criticism and plummeting stock prices. The company is ensnared in a US legal battle over Monsanto's weedkiller Roundup and faces setbacks in its pharmaceutical division. Anderson remains determined amidst criticism, outlining plans for internal reorganization. While facing resistance, Anderson's strategies draw on his extensive experience and are aimed at enhancing value creation. Despite challenges, Anderson remains optimistic and determined to lead Bayer through its difficulties.